morning conference our you Good thank quarter joining and for second XXXX Matt. Thanks call.
Looking at we the the the quarter second have time XXXX. of second XXXX, which we the and is of revenue generated quarter $XXX.X million, X.X% $X million total threshold the first quarter growth of surpassed over for reflects record of
second in period Direct approximate comparative headcount XXXX, due increased sales to sales the an XXXX of reduction representative to by prior consumer over quarter of million in year. XX% quarter the of representative primarily $XX.X partially the of sales the offset productivity, in XX% increased second
we than loss reps did representative sales Furthermore it XXXX higher quarter, improvements the was in expected the of not as than productivity attrition level The in expectations. offset more many targets. quarter, sales while meet hired to representative unable of that sales our sales the the headcount second meet were in in our
performing larger scaled the a benefit trials leads to top across group where not when allocated early representatives, this we generate initiative did successful we anticipated. Despite more
fourth than improvements, sales less sales reduced to XXXX. quarter the the headwinds growth representative productivity expected we and to realize in expect consumer and and direct headcount Given to third of
capacity the all three XXXX. across expansion restarted August facilities we productivity, new sales have our improved in hired realized sales representatives with efforts With
in did a and onboarding. at hire what training infrastructure necessary we believe we sales and changes support XXXX, to Going to forward, management our making we to improve plan controlled sales we more the are than pace
made personnel predictability. better management sales also changes and We have to key to drive productivity, attrition lower improved
be to largest significantly driver year headcount year-end down end at is However, reduced expectations. XXXX the compared which we expect XXXX, of revenue representative XXXX sales to our
Given the we’re expansion sales to number monthly a to to leads the growth. believe consistently generate drive of productivity on need penetrated, revenue execute market but plans direct-to-consumer our basis, remains under future able capacity we we and
second primarily of of of patient’s the revenue to XXXX patients of approximately of on a as had second quarter due compared X.X% rental service, quarter XXXX. X% revenue rental the million per on partially of XXXX, Second $X.X quarter We decreased patient. by XX,XXX service higher to decrease of end offset the
change In XXXX, team until plans early to modest initiated not meaningful separate rental we our rental our a but of we this quarter and contribution criteria the fill did a to team, made from expect a intake second XXXX.
modestly Due reduction of in XXXX, separate rental as revenue to inspite to changes down a sales rental expect increase to changes criteria we the to the the revenue team. in rental intended intake be such establishing rental headcount, and now
service of expecting in on patients service both back-half and the of and rental XXXX on the in from to to we’re patients expect We XXXX. revenue XXXX increase second increase quarter
a of our second we earnings the in second in call provider that sales in XXXX, revenue XX% The through to second who down primarily large a Second XXXX, XXXX. from have in of XXXX partner in $XXX,XXX domestic sales of due quarter due purchased a $X.X and to national $XX.X our quarter internet label quarter business-to-business the to private of decline large last decline sales from secondarily, partners. discussed provider for the accounted to quarter reseller decreased our national million of million
orders second spring internet of XXXX down XXXX not partners second Sales our in partners seen the to increase seasonal the months. as quarter in quarter did summer versus our of reseller previous in and were as typical reseller see
and continue Excluding customers. demand this internet HME provider strong we to traditional sales one national see partners, our reseller to from
due efforts, lack purchase oxygen and to available that will access capital portable convert and credit concentrators, constraints. expenditure to we to be restructuring expect to continue providers HME provider of ongoing continue of While challenged growth
that to and that continue limit certain or reduce us intend have providers we in subject the As they to indicated constraints, be communicated they the in discussed have providers purchases capital future. have to HME to past,
Additionally, investments year with and in more the we conservative competitive contracts believe providers rates. to capital lack around to visibility next will reimbursement the of pending due will be and win bidding changes in XXXX who
we market market under still we patient a demand strong have though product the is offering. leading and Even is believe penetrated,
providers and remainder we are our internet resellers customers, lowering for growth Given for of the these challenges expectations uncertainties HME and for business-to-business our XXXX.
POC’s of $XX.X key constant a reported European preferred as sales XX.X% growth remain were basis, on European million, for strong representing we X.X% at and Second quarter XXXX provider business-to-business international currency underlying account. the trends solid remain of demand
this Transitioning technology have launched in with Inogen leadership GX, position to strengthened the and One the consumer believe direct we April our to channel we in we product. XXXX,
a lightest than As the oxygen. milliliters is reminder, market product of and this that oxygen produces portable quietest greater smallest, the concentrator XXXX today on
in on international we and domestic communicated by each rollout the of expect our XXXX, regulatory pending clearances call, the XXXX first quarter standard to Inogen then to As to quarter business-to-business market. the channel third of the in end business-to-business One channel GX
plan opened publicly. XX, the On but bidding XXX the to strategy Bids September in we bidding betting as window cannot are competitive regions, XXXX. of XXXX, expected topic bid July of We our discuss by XX, due around XXX still XXXX.
We of of be expect contract announced announced X, and into pricing XXXX, winners in in fall be contracts before to XXXX. the go summer the to January XXXX effect
area provided higher tools, bidding the accounts can data, XXXX of competitive versus CMS penetration CBA each preparation by In part around we XXXX are competitive code. bid that non fee-for-service CBAs bidding evaluating areas. beneficiary now Medicare each see in POCs HCPCS for As XXXX traditional and rates this for
Medicare XXXX for total traditional while and U.S. XX.X%, in oxygen CBAs. POC’s was penetration was In the the total it XX% market rate
progress, XX%. the XXXX. for total are know in penetration is we rate is the total penetration market XX.X% in to XXXX but still can estimated term in long POCs the traditional in service XXXX, While full of U.S. we our believe for data October we a Medicare published way oxygen rate beneficiary that the was therapy until penetration see we fee XX% adoption continuing CBA’s from POC won’t to market compared long
to discussing a to Now and of from manufacturer portable of announcement ventilators the Agreement signing suffering New diseases. various significant some like Definitive of today the non-invasive innovative people developer I’d for spend an time Acquire lung chronic Aera,
excited payment of regulatory $XX.X to announce for assets at million plan very and closing, million are of earn-out and performance sales with $XX.X We based to payments from cash Aera clearances. potential on acquire related New future certain a certain up a our entity, to
and position increase natural a and to current oxygen We strengthens believe our products services. independence aligns freedom Ventilator our innovative New it for and market, and our core is nasal with Aera which business innovator and an through with option therapy as fit interface our therapy patients, mission
We preference Tidal technology make technology plan maintain Inogen One oxygen product Stationary Concentrator At-Home therapy to into Concentrators Assist® SideKick incorporate Ventilator or continue with and and long to advance the our the compatible directly leadership term our market. Oxygen Portable Inogen the TAV to TAV patient position our in
use with a to completed small with alone severe lung of COPD TAV or oxygen, oxygen peer-reviewed very their just standard interstitial patients trial comparing clinical Aera moderate the SideKick New either for product disease.
our therapy and able markedly and to less showed trial oxygenation fatigue with leg TAV therapy that The these oxygen a additional XXX% than responded on were opportunity. of patients this oxygen patients will XX% retail strengthen trial to exercise increase. The alone. longer versus indicated oxygen allow We on dyspnea to product better allow and and an alone on XX% therapy us portfolio and positively believe showed endurance TAV mean sales
the growing plan million ventilation addressable fee-for-service as XXXX claims beneficiaries an estimated market. traditional high market U.S. We non-invasive to paid NIV for XXXX. to be and to in use based technology market on per opportunity at into platform $XXX has Medicare of over expand over estimate the our addition we year a since total addressable NIV growth XX% this or In
worldwide there believe a significant opportunity. untreated market We is
reimbursement around inclusion NIV of to XXXX could to undergo competitive similar NIV We nature and the immobile offerings. given pending this product legacy disruption market also of changes oxygen due bidding believe and category the the the
allow HCPCS rate at for $XXX that month. to a January The than of effective ventilator products billing includes has Medicare multi-function a Also new been a therapy, monthly Medicare oxygen ventilation for minimum XXXX X, reimbursement added oxygen. and significantly higher NIV code is
to a targeting are in XXXX. product launch purpose for this We
pocket that the an be expertise. consumer not over patients to represents particularly an XXX COPD help of to Furthermore, breathlessness, to a that during and attractive used this of in currently reduce opportunity market oxygen existing new willing are million therapy to worldwide out who we This are portion can adjacent direct believe technology for our would pay exercise. us technology leverage on
product TAV inside direct-to-consumer force position SideKick consumers and existing We sales plan customers the to to to and through our sell also sales business-to-business force our worldwide.
X SideKick oxygen, SideKick is chronic higher ventilator prescription various can diseases. oxygen patients per design non-invasive approximately to is and oxygen concentrators, flow wall for a of TAVs one gas, minute compatible and liters pressure unique certain required designed with therapy. and providing cylinders is The ounces versus oxygen TAV select five deliver with lung and traditional
believe TAV We the gross SideKick to in we therapy versus be it will accretive expect margin of begin product existing oxygen business. sales XXXX our and
sales growth from associated Looking direct results, to revenue guidance million, XXXX expectations in million, versus year X.X% primarily million consumer we representing $XXX down our X.X% total million with year of reducing to to to reduced $XXX are to XXXX full XXXX, full channel. $XXX $XXX of
expect quarter domestic revenue of the the of compared be XXXX in in year. negatively third to expected to our a We XXXX both channels. productivity the compared to the down increase sales third domestic reduction and period headwinds due headcount impacted direct-to-consumer In the of be to in will sales the representatives, prior of business-to-business same in spite by in quarter sales direct-to-consumer
in Given in XXXX channel, the of domestic domestic challenges face the third and to of sales the the reseller XXXX. difficult expect quarter compared business-to-business declines purchases, the we restructuring providers growth of business-to-business third channel comparisons in some internet the decrease quarter we the in
seen a have headwinds, currency easier of fourth remainder modest in compared quarter in expect of XXXX the rate spite of for lower to international the to of due XXXX We quarter in the growth XXXX. to sales rate business-to-business XXXX growth fourth comparables with
service sales slight of to We we intake now number the XXXX. the change of in revenue in XXXX on to expect second the modestly down in to in reductions do to due the XXXX rental spite of but expect increasing criteria from back-half headcount, be quarter of begin patients
expect XXXX we Lastly, contributions in do the contribute is not to but XXXX. New Aera expected materially to transaction Inogen’s revenue,
we believe double today, XXXX. not growth XXXX can to While revenue providing we plan to execute we return are guidance in on our digit
to I our turn the now Bauerlein. Ali. over call CFO, Ali that, will With